SCHEMBL31312170

SCHEMBL31312170

CCCCCCCC(=O)C(CC)(C(=O)O)C(C)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 8/20 0.47
▸ CES1 P23141 5/20 0.47
▸ CES2 O00748 2/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ HSD17B10 Q99714 2/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ PPARG P37231 6/20 0.44
▸ PPARD Q03181 6/20 0.44
▸ PPARA Q07869 6/20 0.44
▸ HDAC11 Q96DB2 5/20 0.44
▸ TSHR P16473 4/20 0.44
▸ GPR84 Q9NQS5 4/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ TLR2 O60603 2/20 0.44
▸ TDP1 Q9NUW8 2/20 0.44
▸ FABP4 P15090 2/20 0.44
▸ PTPN1 P18031 2/20 0.44
▸ SLC22A6 Q4U2R8 1/20 0.44
▸ SLC22A8 Q8TCC7 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31312434 0.98 FAAH (0.46) FAAHCES1CES2MEN1KMT2A
SCHEMBL31312418 0.88 FAAH (0.46) FAAHCES1CES2MEN1KMT2A
SCHEMBL29286444 0.79 FAAH (0.50) FAAHCES1CES2MEN1KMT2A
SCHEMBL10316723 0.73 FFAR4 (0.45) FAAHCES1CES2MEN1KMT2A
SCHEMBL9338960 0.73 FFAR4 (0.45) FAAHCES1CES2MEN1KMT2A
SCHEMBL9338956 0.73 FFAR4 (0.45) FAAHCES1CES2MEN1KMT2A
SCHEMBL10359003 0.73 FAAH (0.42) FAAHCES1CES2MEN1KMT2A
SCHEMBL23303902 0.73 FAAH (0.52) FAAHCES1CES2MEN1KMT2A
Octanoic Acid SCHEMBL7752426 0.72 GPR84 (0.59) MEN1KMT2AHSD17B10CYP1A2PPARG
SCHEMBL29286401 0.72 FAAH (0.47) FAAHCES1CES2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250009707-A1 METHODS OF INDUCING KETOSIS IN NON-HUMAN MAMMALS BOPZ Nutrition Ltd. (GB) 2025-01-09 — — US claimed
EP-4483869-A1 KETONE ESTERS FOR USE IN INDUCING KETOSIS IN NON-HUMAN MAMMALS BOPZ nutrition Limited (IM) 2025-01-01 — — EP claimed
US-20250009707-A1 METHODS OF INDUCING KETOSIS IN NON-HUMAN MAMMALS BOPZ Nutrition Ltd. (GB) 2025-01-09 — — US disclosed
EP-4483869-A1 KETONE ESTERS FOR USE IN INDUCING KETOSIS IN NON-HUMAN MAMMALS BOPZ nutrition Limited (IM) 2025-01-01 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250009707-A1 METHODS OF INDUCING KETOSIS IN NON-HUMAN MAMMALS GLS2, KHK, CPT1A FAAH 498/4885CES1 45/4885CES2 232/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback